Your browser doesn't support javascript.
loading
Heterozygous variants in ZBTB7A cause a neurodevelopmental disorder associated with symptomatic overgrowth of pharyngeal lymphoid tissue, macrocephaly, and elevated fetal hemoglobin.
von der Lippe, Charlotte; Tveten, Kristian; Prescott, Trine E; Holla, Øystein L; Busk, Øyvind L; Burke, Katherine B; Sansbury, Francis H; Baptista, Júlia; Fry, Andrew E; Lim, Derek; Jolles, Stephen; Evans, Jennifer; Osio, Deborah; Macmillan, Carol; Bruno, Irene; Faletra, Flavio; Climent, Salvador; Urreitzi, Roser; Hoenicka, Janet; Palau, Francesc; Cohen, Ana S A; Engleman, Kendra; Zhou, Dihong; Amudhavalli, Shivarajan M; Jeanne, Médéric; Bonnet-Brilhault, Frédérique; Lévy, Jonathan; Drunat, Séverine; Derive, Nicolas; Haug, Marte G; Thorstensen, Wenche M.
Afiliação
  • von der Lippe C; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Tveten K; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Prescott TE; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Holla ØL; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Busk ØL; Department of Medical Genetics, Telemark Hospital Trust, Skien, Norway.
  • Burke KB; All Wales Medical Genomics Service, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
  • Sansbury FH; All Wales Medical Genomics Service, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
  • Baptista J; Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
  • Fry AE; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
  • Lim D; All Wales Medical Genomics Service, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, UK.
  • Jolles S; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • Evans J; Clinical Genetics, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Osio D; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, UK.
  • Macmillan C; Department of Paediatrics, University Hospital of Wales, Cardiff, UK.
  • Bruno I; Clinical Genetics, West Midlands Regional Genetics Service, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Faletra F; Department of Pediatrics, University of Chicago, Chicago, Illinois, USA.
  • Climent S; Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
  • Urreitzi R; Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
  • Hoenicka J; Pediatrics Service, Hospital General d'Ontinyent, Ontinyent, Spain.
  • Palau F; Department of Clinical Biochemistry and CIBERER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Cohen ASA; Laboratory of Neurogenetics and Molecular Medicine - IPER and CIBERER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Engleman K; Laboratory of Neurogenetics and Molecular Medicine - IPER and CIBERER, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Zhou D; Department of Genetic Medicine - IPER, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Amudhavalli SM; Hospital Clínic and Division of Pediatrics, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Jeanne M; Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Bonnet-Brilhault F; Genomic Medicine Center, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Lévy J; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri, USA.
  • Drunat S; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri, USA.
  • Derive N; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Haug MG; Kansas City School of Medicine, University of Missouri, Kansas City, Missouri, USA.
  • Thorstensen WM; Division of Clinical Genetics, Children's Mercy Hospital, Kansas City, Missouri, USA.
Am J Med Genet A ; 188(1): 272-282, 2022 01.
Article em En | MEDLINE | ID: mdl-34515416
ABSTRACT
By clinical whole exome sequencing, we identified 12 individuals with ages 3 to 37 years, including three individuals from the same family, with a consistent phenotype of intellectual disability (ID), macrocephaly, and overgrowth of adenoid tissue. All 12 individuals harbored a rare heterozygous variant in ZBTB7A which encodes the transcription factor Zinc finger and BTB-domain containing protein 7A, known to play a role in lympho- and hematopoiesis. ID was generally mild. Fetal hemoglobin (HbF) fraction was elevated 2.2%-11.2% (reference value <2% in individuals > 6 months) in four of the five individuals for whom results were available. Ten of twelve individuals had undergone surgery at least once for lymphoid hypertrophy limited to the pharynx. In the most severely affected individual (individual 1), airway obstruction resulted in 17 surgical procedures before the age of 13 years. Sleep apnea was present in 8 of 10 individuals. In the nine unrelated individuals, ZBTB7A variants were novel and de novo. The six frameshift/nonsense and four missense variants were spread throughout the gene. This is the first report of a cohort of individuals with this novel syndromic neurodevelopmental disorder.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Megalencefalia / Transtornos do Neurodesenvolvimento / Deficiência Intelectual Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Megalencefalia / Transtornos do Neurodesenvolvimento / Deficiência Intelectual Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article